Characterizing Disease Severity, Comorbidities, and Treatment Plans in Pediatric Hidradenitis Suppurativa Patients With and Without Obesity: A Cohort and Cross‐Sectional Analysis
In this study, obesity was not associated with HS disease severity in children. However, children with obesity were more likely to be prescribed biologics. HS may independently increase the risk of dyslipidemia, anxiety, depression, and thyroid disease.
Authors
- Asfia Numani (ORCID: https://orcid.org/0000-0002-3272-8886)
- Rachel Ziebart
- Austin W. Todd (ORCID: https://orcid.org/0000-0002-6115-4770)
- Dawn Marie R. Davis (ORCID: https://orcid.org/0000-0001-6819-6044)
- Nessa Aghazadeh (ORCID: https://orcid.org/0000-0002-4641-4626)
- Afsáneh Alavi (ORCID: https://orcid.org/0000-0003-1171-4917)
Institutions
- Mayo Clinic (US)
- WinnMed (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Pediatric Dermatology
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1111/pde.15983
- Primary Topic
- Hidradenitis Suppurativa and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health